本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vaccinex Inc.

0.6900
+0.091915.37%
成交量:1.40萬
成交額:9,589.12
市值:184.69萬
市盈率:-0.08
高:0.7000
開:0.5615
低:0.5615
收:0.5981
52周最高:1.40
52周最低:0.2521
股本:267.66萬
流通股本:131.64萬
量比:31.82
換手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-8.8778
每股收益(LYR):-8.8778
淨資產收益率:-759.09%
總資產收益率:-376.08%
市淨率:-0.44
市盈率(LYR):-0.08

資料載入中...

2025/04/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/19

重要事件披露

Form 8-K - Current report
2025/03/17

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/07

重要事件披露

Form 8-K - Current report
2024/12/17

重要事件披露

Form 8-K - Current report
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/22

SEC問詢函

Form CORRESP - Correspondence
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/20

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/20

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/19

重要事件披露

Form 8-K - Current report
2024/09/13

重要事件披露

Form 8-K - Current report
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report